Cost Per Effectively Treated Patient With Evolocumab 140mg,...

Journal of Clinical Lipidology 2016 / 05 Vol. 10; Iss. 3

Cost Per Effectively Treated Patient With Evolocumab 140mg, Alirocumab 75/150mg Among Patients Using PCSK9 Inhibitor Therapy

Gitlin, Matthew, Meridor, Nathaniel, Whang, John, Patel, Jeetvan, Bonafede, Machaon, Harrison, David
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Language:
english
Journal:
Journal of Clinical Lipidology
DOI:
10.1016/j.jacl.2016.03.056
Date:
May, 2016
File:
PDF, 55 KB
english, 2016
Conversion to is in progress
Conversion to is failed